Punjab bans advertisements by doctors

Chandigarh, Oct 30 (IANS) The Punjab government Sunday announced a ban on advertisements by doctors – from allopathic, ayurvedic and homoepathic streams – offering treatment of various diseases, including sexual ailments.

“Registered medical pract

itioners (RMPs) of homoeopathy, ayurveda and allopathy issuing advertisements and promising assured treatment of various ailments, including sexual ailments, are in for trouble, as the Punjab government has decided to tighten the noose on them,” a spokesman quoting Medical Education and Research Minister Arunesh Shakir said Sunday.

Shakir issued directions to initiate action against all those doctors who were advertising through various media, including print, broadcast and outdoor media, for treatment of various ailments.

He also issued directions to start a campaign to stop advertisements by RMPs as these were in violation of the guidelines of the Medical Council of India.

The minister said that it was unfortunate that some medical practitioners dealing in homoeopathy, ayurveda and allopathy were giving advertisements and putting up hoardings offering total rejuvenation in cases of sexual problems and assuring the birth of male child.

Punjab has one of the worst sex ratio among all states in the country at 893 females per 1,000 males.

“It is unethical as well as illegal for a doctor to advertise and any doctor issuing advertisements would be issued show cause notice by the affiliating body and proceedings would be launched for the cancellation of his licence,” said the minister.

Just be nice to others to make the world full of kind people

London, September 20 (ANI): Spreading altruism through social networks can make people across the world kind to one another, says an expert.

Nicholas Christakis, of Harvard Medical School in Boston, has observed in a study that one’s kindness can turn a friend kind to someone else he/she knows.

To demonstrate this, Christakis designed a cooperation game in which 120 students were organised into groups of four, and asked to give money to their group.

The game lasted five rounds, and after each round the students were reorganised so that no two appeared in the same group twice.

At the end of each found, the participants were told how much the others in their group had given.

Christakis observed that if someone gave a dollar more than the predicted group average, the others in that group gave approximately 20 cents more than expected in the next round.

The altruism persisted into the third round, said the researcher.

A separate study conducted by Christakis’s team showed that cooperative behaviour spreads to three degrees of separation, from friend to friend to friend, reports New Scientist.

Based on their observations, Christakis and colleagues came to the conclusion that a person who is popular and well connected could have a special role to play, as his/her compassionate acts could resonate further through the network, and he/she was also more likely to benefit from other people’s kindness. (ANI)

Natural hydrogel may boost spinal cord healing

Washington, Sep 18 (ANI): A jab of biomaterial gel into a spinal cord injury site may significantly improve healing, according to researchers at the Barrow Neurological Institute at St. Joseph’s Hospital and Medical Center.

Dr. Mark Preul and Dr. Alyssa Panitch have found in a study that injection of an engineered hydrogel made up mainly of hyaluronic acid (a naturally-occurring body substance) into the spinal cord injury site decreases scarring, and promotes a realignment of the spinal cord fibres around the injury site.

The hyaluronic acid, which forms a scaffold-like configuration may help to structurally stabilize the spinal cord injury site.

The researchers traced cells in the brain stem after injury, and found much higher levels in the hydrogel treated animals as compared to animals that did not receive the treatment, and approached nearly normal levels.

Treated animals had higher functional scores than their non-treated counterparts.

“Spinal cord injury is devastating to civilian and military populations – especially to the young. There has been little progress toward paradigms of regeneration and few results that show real, sustained functional recovery. We’ve been so pre-occupied with regeneration, but that is a highly complicated and difficult to define goal. This project is a synergy of neurosurgeons and bioengineers that attempts repair of the SCI lesion cavity using a tissue-engineering biomaterials approach,” says Preul.

He added that the team aimed at finding ways to structurally allow the body to better heal itself.

“In this project we did not add anything to the hyaluronic acid. It may be that adding growth factors or cells into the gel matrix may allow even better results,” he said.

Preul said that the results show “we may be on a practical path that can give hope to the many people who suffer this sort of injury.”

The work was presented at the Annual Meeting of the American Association of Neurological Surgeons in San Diego where it won the Synthes Prize for Spine Research. (ANI)

‘Two for one’ breast boosting technique not as viable as it seems

London, Sep 16 (ANI): A technology that was claimed as the ultimate solution to give a boost to women’s breasts by using fat removed from thighs is not viable as it seems, say experts.

Mel Graham, chairman of the Harley Medical Group, recently claimed that the “two for one” procedure could extract excess fat from where it was not wanted – the belly, hips or thighs – and relocate it to the bust.

However, rival cosmetic surgeons criticised the “hype” surrounding the new operation, insisting that it was “premature”.

“(This) is setting consumers up for disappointment and there are many reasons for vigilance,” the Independent quoted Dai Davies, of Plastic Surgery Partners in Harley Street, as saying.

He said that doctors have long been experimenting with innumerable aids to give women larger busts, including using body fat as a procedure.

The technique of removing fat by liposuction, and then injecting it into the chest has been tried for almost 20 years but with limited success, said Davies.

“Where you are injecting small amounts of fat into the face, which has a good blood supply, there is good evidence that it works. Most plastic surgeons would agree there is a place for it. But this involves injecting a large blob of fat into the breast area. Fat consists of living cells and living cells must have a blood supply, otherwise they die,” he explained.

In a Japanese study last year, 230 women underwent fat transfer, and it was found that, on average, half the fat injected was lost and all the women needed a second procedure after a year.

There are also fears that dying fat cells could cause micro-calcification in the breast leading to difficulties in breast screening and an increase in biopsies – an invasive procedure to remove tissue to check for cancer.

“I don’t think we should be a testing ground for all these techniques. You are feeding on a susceptible group of people. There should be controls but, sadly, the Government has decided it won’t implement regulation,” said Davies.

Professor David Sharpe, a plastic surgeon in Yorkshire and the founding chairman of the breast special interest group of BAAPS, said: “This sounds like another example of creative marketing. Breast implants are a well-tried and tested method. At the moment, I would stick with that.”

Mel Braham, chairman of the Harley Medical Group, said results of a US trial to be presented next month would demonstrate the success of the operation.

“The results will be assessed by our medical board and, if approved, the operation will be introduced next year. I don’t take risks with patients. I am confident this is a safe procedure,” he said. (ANI)

Exercise beats shockwaves for chronic shoulder pain

London, Sept 16 (ANI): Supervised exercise helps ease chronic shoulder pain better than sound shockwave treatment, a new study suggests.

In the study, published in the online British Medical Journal, team of researchers based in Oslo, Norway compared the effectiveness of radial extracorporeal shockwave treatment (low to medium energy impulses delivered into the tissue) with supervised exercises in patients with shoulder pain.

The research involved 104 men and women aged between 18 and 70 years.

Participants were randomised to receive either radial extracorporeal shockwave treatment (one session weekly for four to six weeks) or supervised exercises (two 45 minute sessions weekly for up to 12 weeks).

Both groups were similar at the start of the study with regard to age, education, dominant arm affected and pain duration.

All patients were monitored at six, 12 and 18 weeks and were advised not to have any additional treatment except analgesics (including anti-inflammatory drugs) during the follow-up period. Pain and disability were measured using a recognised scoring index.

After 18 weeks, 32 of patients in the exercise group achieved a reduction in shoulder pain and disability scores compared with 18 in the shockwave treatment group.

More patients in the exercise group returned to work, while more patients in the shockwave treatment group had additional treatment after 12 weeks, suggesting that they were less satisfied.

The authors conclude: “Supervised exercises were more effective than radial extracorporeal shockwave treatment for short term improvement in patients with subacromial shoulder pain.” (ANI)

Popular diabetes drug may help fight breast cancer

Washington, Sept 15 (ANI): A popular diabetes drug called metformin has been found to be effective in fighting breast cancer.

The findings of the study from Harvard Medical School showed that metformin, along with conventional chemotherapy, shows promise for treating and delaying recurrence of breast cancer.

“We have found a compound selective for cancer stem cells,” said senior author Kevin Struhl, the David Wesley Gaiser professor of biological chemistry and molecular pharmacology at HMS.

“What’s different is that ours is a first-line diabetes drug,” he added.

The drug seemed to work independently of its ability to improve insulin sensitivity and lower blood sugar and insulin levels, all of which are also associated with better breast cancer outcomes.

“There is a big desire to find drugs specific to cancer stem cells,” said Struhl.

“The cancer stem cell hypothesis says you cannot cure cancer unless you also get rid of the cancer stem cells. From a purely practical point of view, this could be tested in humans. It’s already used as a first-line diabetes drug,” he added.

Lead researchers Heather Hirsch and Dimitrios Iliopoulos found that the combination of metformin and the cancer drug doxorubicin killed human cancer stem cells and non-stem cancer cells in culture.

In mice, pre-treatment with the diabetes drug prevented the otherwise dramatic ability of human breast cancer stem cells to form tumours.

In cases where tumours were allowed to take hold for 10 days, the dual therapy also reduced tumour mass more quickly and prevented relapse for longer than doxorubicin alone.

“This is an exciting study,” said Jennifer Ligibel, a medical oncologist at Dana-Farber Cancer Institute and an HMS instructor in medicine, who was not involved in the study.

“There is a lot of interest in studying metformin in breast cancer, but so far we do not have direct evidence that metformin will improve outcomes in patients,” Ligibel said. “That’s what this trial is for.”

The findings appear online in the journal Cancer Research. (ANI)

Popular stomach acid reducer ups patients’ risk of developing pneumonia threefold

Washington, September 15 (ANI): Researchers at Wake Forest University School of Medicine have found that a popular stomach-acid reducer, which is used to prevent stress ulcers in critically ill patients who need breathing machine support, triples the likelihood of contracting pneumonia among such patients.

Hospital-acquired pneumonia-the leading cause of infection-related deaths in critically ill patients-increases hospital stays by an average of seven to nine days, cost of care, and the risk of other complications.

“As best we can tell, patients who develop hospital-acquired pneumonia or ventilator-acquired pneumonia have about a 20 to 30 percent chance of dying from that pneumonia. It’s a significant event,” said senior study author Dr. David L. Bowton, professor and head of the Section on Critical Care in the Department of Anesthesiology.

During the study, the researchers compared treatment with two drugs that decrease stomach acid: ranitidine, marketed under the name ZantacTM, and pantoprazole, marketed under the name ProtonixTM or PrilosecTM.

Both drugs decrease stomach acid, but the newer pantoprazole is considered more powerful, and has become the drug of choice in many hospitals.

However, upon the analysis of 834 patient charts, the researchers came to the conclusion that the risk of developing pneumonia was thee times more in the hospitalised cardiothoracic surgery patients who had been treated with pantoprazole.

“We conducted this study, in part, because we thought we were seeing more pneumonias than we were used to having,” said study co-author Marc G. Reichert, pharmacy coordinator for surgery at Wake Forest University Baptist Medical Center.

The researchers say that their study suggests some other steps to keep critically ill patients from developing ventilator-associated pneumonia.

Bowton suggests that doctors consider whether an acid reducer is needed at all, and, in cases where it is needed, ranitidine is recommended because of the apparent decreased risk in developing pneumonia.

Doctors should stop using the drug as soon as the risk of bleeding passes – once the patient is off the breathing machine and eating, either on his/her own or through a feeding tube.

“Stopping the drugs earlier appears to be the best thing for patients,” Reichert said.

The study has been published in a recent issue of CHEST. (ANI)

14 policemen injured in Mansehra jail bomb blast

Mansehra (Pakistan), Sep. 14 (ANI): At least 14 policemen were injured, three of them critically, in a remote control bomb blast near Central Jail here on Monday.

The Nation quoted the District Police Officer Akhtar Hayat Khan Gandapur, as saying that the bomb placed alongside the road, went off when a police van was passing by.

He said that van was carrying prisoners from the Central Jail to Abbottabad for the hearing of cases.

The injured were evacuated to District Headquarters Hospital Mansehra where emergency has been declared. The three critically injured policemen were shifted to Ayub Medical Complex Abbottabad. (ANI)

No toxic substance found in Urumqui’s latest syringe attack victims’ body

Urumqui, Sep. 14 (ANI): The blood samples of Urimqui’s latest syringe attack victims showed no trace of radioactive, toxic or viral substances, such as AIDS, an expert at a Beijing-based laboratory has said.

However, Director of Disease Control and Biological Security Office with China’s Academy of Military Medical Sciences, Qian Jun, has said that the victims have showed signs of depression.

“Although no radioactive or toxic substances were found, some patients showed various levels of anxiety and depression and have been recommended for psychological counselling,” China daily quoted Quian, as saying.

Meanwhile, the first group of syringe attack suspects were prosecuted in Urumqi, capital of the Xinjiang Uygur autonomous region.

At least 500 cases of attacks have surfaced in the city since mid-August.

Two men and a woman were given sentences ranging from seven to 15 years in jail for syringe stabbings or robberies in which they threatened their victims with needles.

The court sentenced 19-year-old Yilipan Yilihamu to 15 years in prison for injecting a woman with a hypodermic needle on August 28 at a roadside fruit stall. (ANI)

Master gene that switches on disease-fighting cells identified

London, Sep 14 (ANI): British scientists have identified the master gene, called E4bp4, that causes blood stem cells to turn into disease-fighting ‘Natural Killer’ (NK) immune cells.

The discovery, by researchers at Imperial College London, UCL and the Medical Research Council’s National Institute for Medical Research, could one day help scientists boost the body’s production of these frontline tumour-killing cells, creating new ways to treat cancer.

By ‘knocking out’ E4bp4 in a mouse model, the researchers created the world’s first animal model entirely lacking NK cells, but with all other blood cells and immune cells intact.

The breakthrough model should help solve the mystery of the role that Natural Killer cells play in autoimmune diseases, such as diabetes and multiple sclerosis.

According to many scientists, these diseases are a result of malfunctioning NK cells that turn on the body and attack healthy cells, which cause disease instead of fighting it.

They believe that clarifying NK cells’ role could lead to new ways of treating these conditions.

Natural Killer cells – a type of white blood cell – are a major component of the human body’s innate, quick-response immune system, providing a fast frontline defence against tumours, viruses and bacterial infections.

The gene E4bp4 is the ‘master gene’ for NK cell production, which means it is the primary driver that causes blood stem cells in the bone marrow to differentiate into NK cells.

Led by Dr Hugh Brady, the researchers are hoping to progress with a drug treatment for cancer patients which reacts with the protein expressed by their E4bp4 gene, causing their bodies to produce a higher number of NK cells than normal, to increase the chances of successfully destroying tumours.

“If increased numbers of the patient’s own blood stem cells could be coerced into differentiating into NK cells, via drug treatment, we would be able to bolster the body’s cancer-fighting force, without having to deal with the problems of donor incompatibility,” Nature quoted Brady as saying.

The researchers proved the pivotal role E4bp4 plays in NK production when they knocked the gene out in a mouse model.

Without E4bp4 the mouse produced no NK cells whatsoever but other types of blood cell were unaffected.

“Now finally, with our discovery of the NK cell master gene and subsequent creation of our mouse model, we will be able to find out if the progression of these diseases is impeded or aided by the removal of NK cells from the equation. This will solve the often-debated question of whether NK cells are always the ‘good guys’, or if in certain circumstances they cause more harm than good,” said Brady.

The study has been published in Nature Immunology. (ANI)

World’s first patient implanted with smallest rechargeable neurostimulator completes one year

Washington, Sep 12 (ANI): The world’s first patient to have been implanted with the smallest ever neurostimulator for chronic pain is celebrating the one-year anniversary of his procedure today.

One year ago, former U.S. Army parachutist Adam Hammond became the first patient in the world to have been implanted with an Eon Mini neurostimulator.

Adam got the chronic pain after a skydiving accident when his parachute deployed incorrectly, leaving him in a coma with life-threatening injuries, including a severed spine, broken femur, fractured pelvic bone, and torn aorta.

Although Adam recovered from his accident, he battled chronic pain that left him dependent on a wheelchair.

But, today, the picture has completely changed and Adam is active and exercising, studying for his law degree and no longer in need of a wheelchair.

Adam also went to Washington, D.C., recently to meet with representatives and advocate for pain legislation.

However, Adam is not the only chronic pain sufferers who have been helped with neurostimulation, an FDA-approved therapy that uses electrical pulses to interrupt pain signals to the brain.

Over 60,000 St. Jude Medical neurostimulation devices have been implanted in patients in 35 countries around the world. (ANI)

38-year-old Delhi woman dies of swine flu, toll rises to six

New Delhi, Sep.11 (ANI): A 38-year-old woman has become Delhi’s sixth swine flu victim.

Ram Manohar Lohia Hospital Medical Superintendent N.K. Chaturvedi said the victim, Raj Bala, was a resident of Faridabad and had been admitted with swine flu symptoms on September 5. He said that she died this morning.

Bala was both diabetic and hypertensive and had a past history of bronchial asthma.

Chaturvedi said she died of pulmonary edema.

Earlier, a 12-year-old girl, Gauri, a resident of Dwarka had died at the same hospital on Thursday. (ANI)

Why pandemic swine flu causes more severe symptoms than seasonal flu

London, September 11 (ANI): Scientists at Imperial College London have warned that pandemic swine flu can infect cells deeper in the lungs than seasonal flu can.

They write in a research paper that this may help understand why people infected with the pandemic strain of swine-origin H1N1 influenza are more likely to suffer more severe symptoms than those infected with the seasonal strain of H1N1.

The researchers have also stressed the need for monitoring the current pandemic H1N1 influenza virus for any changes in the way it infects cells, which may make infections more serious.

Generally, influenza viruses infect cells by attaching to bead-like molecules on the outside of the cell, known as receptors. If a virus cannot find its specific receptors, it cannot get into the cell.

Seasonal influenza viruses attach to receptors found on cells in the nose, throat and upper airway, enabling them to infect a person’s respiratory tract.

In the current study, the researchers have found that pandemic H1N1 swine flu can also attach to a receptor found on cells deep inside the lungs, which can result in a more severe lung infection.

They say that the pandemic influenza virus’s ability to stick to the additional receptors may explain why the virus replicates, and spreads between cells more quickly.

“Most people infected with swine-origin flu in the current pandemic have experienced relatively mild symptoms. However, some people have had more severe lung infections, which can be worse than those caused by seasonal flu. Our new research shows how the virus does this – by attaching to receptors mostly found on cells deep in the lungs. This is something seasonal flu cannot do,” Nature Biotechnology quoted Professor Ten Feizi, from the Division of Medicine at Imperial College London, as having writte in the research paper.

The researchers found that pandemic H1N1 influenza bound more weakly to the receptors in the lungs than to those in the upper respiratory tract, which is why most people infected with the virus have experienced mild symptoms.

However, the researchers are concerned that the virus could mutate to bind more strongly to these receptors.

“If the flu virus mutates in the future, it may attach to the receptors deep inside the lungs more strongly, and this could mean that more people would experience serious symptoms. We think scientists should be on the lookout for these kinds of changes in the virus so we can try to find ways of minimising the impact of such changes,” said Prof. Feizi.

“Receptor binding determines how well a virus spreads between cells and causes an infection. Our new study adds to our understanding of how swine-origin influenza H1N1 virus is behaving in the current pandemic, and shows us changes we need to look out for,” added Prof. Feizi.

The financial assistance for the study came from the Wellcome Trust, the Medical Research Council and the Engineering and Physical Sciences Research Council. (ANI)

Three genes linked to Lou Gehrig’s disease identified

Washington, Sep 10 (ANI): Researchers at Michigan Technological University have identified three genes that play a major role in the most common type of amyotrophic lateral sclerosis (ALS), generally known as Lou Gehrig’s disease.

The team of mathematicians, led by Shuanglin Zhang, isolated the genes from the many thousands scattered throughout human DNA.

Zhang noted that the discovery does not mean an end to ALS, but it could provide scientists with valuable clues as they search for a cure.

“I felt very urgent to find the genes for ALS,” Zhang said.

“This is very nice work. It’s very challenging to map genes for complex diseases, and while many statistical methods have been developed, most don’t work well in practice. Zhang’s group has developed a method to detect genes and gene-gene interaction in complex diseases and provided evidence that it works,” said Xiaofeng Zhu, an associate professor of epidemiology at Case Western Reserve University’s School of Medicine.

“Their findings will need to be confirmed by other researchers, but I think this will be very useful for the investigators who are trying to find genes underlying complex diseases such as ALS,” said Zhu.

According to the ALS Association, only about 10 percent of patients have familial ALS, a directly inherited form of the usually fatal neuromuscular disorder, while the remaining 90 percent are diagnosed with the sporadic form of the disease.

While everyone has the three genes in question, but in people with sporadic ALS, they differ from those in people who don’t have ALS.

The mathematicians were not surprised when they tracked down the location of the genes.

“Everybody has 23 chromosomes, and the three genes on chromosomes 2, 4, and 10 interact. If you have this combination of the three genes, you are at high risk of developing the disease. It’s really exciting, especially because my husband has sporadic ALS. Maybe they can find a cure by blocking the genes,” explained Zhang’s wife Qiuying Sha.

ALS destroys the nerves in the brain and spinal cord that control voluntary movement, eventually leading to paralysis.

Zhang’s team used a new statistical method to analyse the genetic codes of 547 individuals, 276 with sporadic ALS and 271 without.

The method, a two-locus interaction analysis approach, allows the researchers to identify multiple genes associated with a complex illness.

The data set they analyzed was provided by National Institute of Neurological Disorders and Stroke (NINDS) Human Genetics Resource Center at the Coriell Institute, a publicly funded “bank” or repository for human cells, DNA samples, clinical data, and other information that aims to accelerate research on the genetics of nervous system disorders.

The study has been published in the open access journal BMC Medical Genetics. (ANI)

Satyam founder Raju placed under medial observation for 48 hours

Hyderabad, Sep 8 (ANI): Satyam Computers founder B Ramalinga Raju, who suffered a massive heart attack on Monday, has been put under observation for next 48 hours in the Intensive Care Unit (ICU) of the Nizam’s Institute of Medical Sciences (NIMS) hospital.

According to hospital sources, Raju has also been diagnosed with the Hepatitis C.

Doctors said, Raju’s condition is stable and that he needed rest for a long period.

According to jail sources, Raju suffered a cardiac arrest at around 8 p.m, was initially attended by the jail doctors before being shifted to NIMS hospital.

Raju, who has been under judicial custody at the Chanchalguda jail for the past eight months in connection with Rs 8,000 crore corporate fraud, facing criminal charges including fraud, forgery, cheating, embezzlement and insider trading along with his brother and Satyam’s former managing director Rama Raju and others.

Raju, will turn 55 on September 16.

Raju was Satyam’s Chairman until January 7, 2009 when he resigned from the company’s board after admitting to corporate fraud. The Andhra Pradesh Police arrested him on January 9.

Satyam was created by Raju and others and was until recently perceived to be among the top Indian IT companies. (ANI)

Xinjiang riots: Urumqi party chief, Xinjiang police chief removed

Urumqi, Sep. 6 (ANI): In the aftermath of Xinjiang riots that erupted on July 5, the party chief of Urumqi and police chief of northwest China’s Xinjiang Uygur Autonomous Region have been sacked.

According to a decision by the CPC Xinjiang Autonomous Regional Committee, Li Zhi, secretary of the Urumqi Municipal Committee of the Communist Party of China (CPC), was replaced by Zhu Hailun.

Xinjiang’s police chief Liu Yaohua was also replaced by Zhu Changjie, party chief of Xinjiang’s Aksu Prefecture, Xinhua reports.

Fresh protests broke out this week after hundreds of Urumqi residents said that they were attacked by syringes. Five people were killed in the following protests.

Local hospitals had dealt with 531 victims of hypodermic syringe stabbings by Thursday, 106 of whom showed obvious signs of needle attacks.

Chinese military medical experts on Saturday ruled out the possibility that radioactive substance, anthrax and toxic chemical were used in recent syringe attacks in Urumqi City.

“According to the preliminary test results, such possibilities can be ruled out,” said Qian Jun, director of Disease Control and Biological Security Office with China’s Academy of Military Medical Sciences.

Samples had been sent to Beijing for further test, he added.

Xinjiang police has captured 25 suspects amid the syringe scare. (ANI)

Army confers Honorary Brigadier Rank on Dr ArvInd Lal

New Delhi, Sep. 4 (ANI): Dr. Arvind Lal, Chairman and Managing Director of Dr. Lal Pathological Laboratories, has been awarded the Honorary Rank of Brigadier by the Armed Forces Medical Services.

President Pratibha Patil, the Supreme Commander of the Armed Forces, granted this award to Dr Lal in recognition to his outstanding contribution in the field of health care.

Dr Lal, alumni of the Armed Forces Medical College (AFMC), is a pioneer in bringing Laboratory services in India at par with the Western world.

Dr Lal also worked as a Demonstrator (Lecturer) in the Department of Pathology in AFMC.

In 1977, Dr Lal took charge of the Pathology Laboratory founded in 1949 by his late father.

Dr Lal has revolutionized laboratory medicine in the country by introducing new tests, instruments and ICT systems i.e. Information, Communications-Technology systems.

A member of many expert and advisory bodies set up by the central and state governments and on the panel of several professional bodies and institutes, Dr Lal has served as a pathologist to many present and past Prime Ministers of India.

Conferred with the Padma Shri award by the President this year, Dr Lal is also a recipient of the Indira Gandhi Solidarity Award in 1994, Delhi Ratan Award in 2005, Lifetime Achievement Award in Medicine in 2003 and the International Business Council Award 1994. (ANI)

Family, friends may affect breast cancer surgery decision

Washington, Sept 1 (ANI): A new study from the University of Michigan Comprehensive Cancer Center has found that about 75 percent of women newly diagnosed with breast cancer are accompanied by a friend or family member during their first visit to a surgeon and that person plays a major role in the patient’s decision of what type of surgery to have.

In the study, the researchers looked at factors affecting a woman’s choice between a mastectomy to remove the entire breast or breast-conserving surgery, which involves removing only the tumor and is followed by radiation treatments.

They found that when the patient, rather than the doctor, drives the surgery decision, the patient is more likely to choose a mastectomy. This proved to be the case among all racial and ethnic groups.

The study also showed that women who had a friend or family member accompany them to the surgical consultation were more likely to receive a mastectomy, compared to women who attended the appointment alone.

Latinas who speak little English were most influenced by family in their decision-making: 75 percent, compared to 34 percent of white women.

“Family and friends have a potentially important role in treatment discussions. More than 70 percent of women brought someone with them to the appointment, providing a chance for surgeons to convey information to both the patient and her support person. Clearly, others help with and contribute to decision making, and may do so differently for different racial or ethnic groups,” says lead study author Sarah Hawley, Ph.D., M.P.H., research associate professor of internal medicine at the U-M Medical School.

Researchers analyzed survey responses from 1,651 women diagnosed with early stage breast cancer in the Detroit and Los Angeles metropolitan areas.

Patients were asked about their surgical treatment decision, including how involved they were in the decision making, whether a family member or friend accompanied them to the appointment and their attitudes toward surgery. Higher numbers of African Americans and Latinas were included.

The study appears online Aug. 31 in the Journal of the National Cancer Institute. (ANI)

How economic recessions affect public health

Washington, September 1 (ANI): A new study suggests that mortality rates during economic recessions in developed countries decline rather than increase.

Publihsed in the Canadian Medical Association Journal (CMAJ), the study also suggests that in poor countries where GDP per capita is less than 5,000 dollars, economic growth appears to improve health by increasing access to food, clean water, shelter, and basic health services.

“In terms of business cycles, mortality is procyclical, meaning it goes up with economic expansions and down with contractions, and not countercyclical (the opposite), as expected,” writes Dr. Stephen Bezruchka, from the School of Public Health, University of Washington in Seattle, USA.

The author points out that studies on wealthy countries show that greater national wealth does not equate with better health for its citizens.

“The United States, with the highest GNP per capita in the world, has a lower life expectancy than nearly all the other rich countries and a few poor ones, despite spending half of the world’s health care bill,” he states.

It also has the highest poverty levels of any wealthy country, with large health disparities and poor health outcomes.

Countries like Sweden, which have strong social safety nets and strong labour protection, see smaller changes in the health of its citizens during recessions.

Bezruchka says that studies have shown that unemployment can be bad for people’s health, yet smoking, excessive alcohol consumption and overeating decline during recessions with beneficial impacts on health.

Perhaps even more importantly, adds Bezruchka, when unemployment rates soar, people have more time for friends, family, and children.

That, according to him, results in lower mortality.

“If we recognize that economic growth may not be good for our health, then we can consider means of reining in the excess wealth… and of redistributing national resources through social spending for the common good,” concludes Dr. Bezruchka. (ANI)

20 minutes of brisk walking can halve death risk for elderly men

London, Aug 31 (ANI): Just 20 to 40 minutes of brisk walking can reduce the risk of death in elderly men by 50pct, according to a US study.

By comparing the death rates in men aged between 70 and 92 who were sedentary with those of varying levels of fitness, the researchers found that for every two minutes of exercise the mortality rate dropped by 10 per cent.

The exercise tests showed that for every 100 men who died in the very low fitness group, 74 died in the next group up, 54 in the moderately fit group, and 46 in the high fit category.

“The overall message is that although ageing and death are inevitable, the rate for both can be modulated by simply maintaining a physically active lifestyle at any age,” the Telegraph quoted Dr. Peter Kokkinos, from the Veterans Affairs Medical Centres in Washington and Palo Alto in California, as saying.

“Although I cannot guarantee that regular exercise will add years to your life, I am quite certain that it will add life to your years. It is important nevertheless to emphasise moderation,” he added.

Kokkinos advised that exercise should be started slowly and gradually.

The findings were presented at the European Society of Cardiology Congress in Barcelona. (ANI)